WO1998041183A1 - Preparations dermatologiques embellissantes - Google Patents
Preparations dermatologiques embellissantes Download PDFInfo
- Publication number
- WO1998041183A1 WO1998041183A1 PCT/JP1998/001095 JP9801095W WO9841183A1 WO 1998041183 A1 WO1998041183 A1 WO 1998041183A1 JP 9801095 W JP9801095 W JP 9801095W WO 9841183 A1 WO9841183 A1 WO 9841183A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- phase
- genus
- skin
- whitening
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
Definitions
- the present invention suppresses the production of melanin by adding an extract of a plant belonging to the genus Solanum (Solanaceae) to prevent and improve pigmentation after sunburn, such as spots, freckles, and liver spots. It relates to effective skin whitening preparations.
- the present invention suppresses the production of melanin by incorporating an extract of a plant belonging to the genus Fabaceae Gliricidia, thereby inhibiting pigmentation, spotting, and pigmentation after sunburn. Freckles ⁇ Skin whitening skin preparations effective for prevention and improvement of melasma etc.
- the present invention suppresses the production of melanin by blending an extract of a plant belonging to the genus Asteraceae (Asteraceae) with the genus Brichellia, thereby suppressing pigmentation and spotting after sunburn.
- Asteraceae genus Asteraceae
- Brichellia genus Brichellia
- melanin pigments are generally formed due to hormonal abnormalities and irritation from ultraviolet rays from sunlight, which are abnormal in the skin. It is believed to be deposited.
- This melanin pigment which causes skin coloring, is produced in melanin-producing granules (melanosomes) in melanin cells (melanosite) between the epidermis and dermis, The produced melanin diffuses to neighboring cells by osmosis.
- the biochemical reactions in this melanosite are estimated to be as follows.
- tyrosin which is an essential amino acid
- tyrosinase which is converted to black melanin through red and colorless pigments by enzymatic or non-enzymatic oxidation.
- the process of changing is the formation process of melanin.
- the present invention is a skin whitening agent for external use characterized by incorporating an extract of a plant of the genus Solanum (Solanaceae) belonging to the genus Solanaceae.
- the present invention provides the skin whitening agent for external use, characterized in that it is the Solanaceae family Solanum genus plant power Junorebeiz (J urubeba paiz, scientific name: Solanum paniculatum). It is. Further, the present invention is characterized in that the blending amount of the extract of the plant of the genus Solanum of the family Solanaceae is 0.00050.10.0% by weight. External preparation for skin.
- the present invention also provides a skin whitening external preparation characterized by incorporating an extract of a plant of the genus Fabaceae Gliricidia.
- the present invention relates to the skin whitening preparation for skin whitening, which is the plant of the genus Fabiaceae Gliricidia belonging to the genus Gliricidia (Cocohuite ⁇ , scientific name: Gliricidia sepium). To provide.
- the amount of the extract of the plant belonging to the genus Gliricidia belonging to the genus Fabaceae is 0.0005.00.0% by weight based on the total amount of the skin external preparation for whitening. %.
- the above-mentioned skin whitening external preparation for skin is provided.
- the present invention provides an external preparation for whitening skin, characterized by comprising an extract of a plant belonging to the genus Asteraceae (Brickellia). It is.
- the present invention also relates to the external use for whitening skin, wherein the Asteraceae (Asteraceae) is a genus of Brickellia (Cocohuite, scientific name: Gliricid ia sepium).
- the agent is provided.
- the blending amount of the extract of the Asteraceae genus Brickellia (Brickellia) plant is 0.0 0.0005 10.0 with respect to the total amount of the whitening skin external preparation.
- the above-mentioned skin whitening agent for external use is provided by weight.
- the plant of the genus Solanum belonging to the family Solanaceae used in the present invention is preferably J. junbe j urubeba paiz (scientific name: Solanura paniculatum). This is a plant that grows especially on dry grasslands and pastures in Brazil.
- the melanin production inhibitory action and tyrosinase inhibitory action of an extract of the Solanaceae family Solanum genus plant are the first effects found by the present inventors, and are applied to whitening agents and skin externalizing agents for whitening. The application of is not known at all.
- the plant of the genus Fabaceae Gl iricidia used in the present invention is preferably Cocohuite (scientific name: Gl iricidia sepium), but is preferably Gli iricidia kunph. ) Etc. are also effective and are not limited to Koko Hi Yuite. Coco Hey is a plant that grows especially on dry grasslands and pastures in Mexico.
- the melanin production inhibitory action and tyrosinase inhibitory action of the extract of the plant belonging to the genus Fabaceae Gliricidia are the effects first discovered by the present inventors. Of course, for skin external preparations It is not known at all.
- the Asteraceae (Brickellia) genus plant used in the present invention is preferably a plant of the genus Nomula (Hamula, scientific name: Brickellia cavanillesy), but is preferred for its use in the case of Ear leaf brickellbush, Scientific name: Brickellia amplexicaulis)
- Scientific name: Brickellia betonicifolia is also effective, and is not limited to Hamiyura. It is a shrub that grows in warm regions.
- the extract used in the present invention is obtained by immersing or heating and refluxing the above-mentioned plant branches, roots, leaves, stems including rhizomes, fruits, flowers, etc., or the whole plant with an extraction solvent, followed by filtration and concentration. Is obtained.
- the extraction solvent used in the present invention is not particularly limited as long as it is a solvent usually used for extraction. Examples thereof include alcohols such as methanol and ethanol, hydrated alcohols, acetate, and ethyl acetate. It is preferable to use these organic solvents alone or in combination.
- the amount of the above plant extract in the present invention is 0.0005 to 10.0% by weight, preferably 0.01 to 5.0% by weight of the total amount of the external preparation as a dry matter. %. If the amount is less than 0.005% by weight, the effects of the present invention cannot be sufficiently exerted. If the amount is more than 10.0% by weight, it is not preferable because the preparation becomes difficult. Also, even if the content is 5.0% by weight or more, the effect is not so much improved.
- the skin whitening preparation of the present invention further comprises components used in skin external preparations such as cosmetics and pharmaceuticals.
- Agents, moisturizers, antioxidants, oily components, UV absorbers, surfactants, thickeners IJ, alcohols, powder components, coloring materials, aqueous components, water, various skin nutrients, etc. as needed Can be blended.
- edetate Trisodium edetate
- sodium citrate sodium polyphosphate
- sodium metalate sodium metalate
- gluconic acid etc.
- Blocking agents caffeine, tannin, verapamil, tranexamic acid and its derivatives, licorice extract, glabridin, hot water extract of fire spike fruit, various crude drugs, tocopherol acetate, glycyrrhizinate and Drugs such as derivatives or salts thereof, vitamin C, magnesium ascorbate phosphate, glucoside ascorbate, arbutin, kojic acid and other whitening agents, glucose, fructoses, mannoic acid Sugars such as sucrose, sucrose, trerose and the like can also be appropriately blended.
- the skin whitening preparation for external use of the present invention may be any of those conventionally used for skin external preparations, such as ointments, creams, emulsions, mouth lotions, packs, bath preparations, etc.
- the type is not particularly limited.
- the compounding amount is% by weight.
- test methods and results of the melanin inhibitory effect, tyrosinase activity inhibitory effect, and whitening effect of the plant extract of the present invention will be described. "Test method and results"
- the branch of Cocohuite ⁇ (scientific name: Gl iricidia sepium) 100 g was immersed in ethanol at room temperature for one week, and the extract was concentrated to obtain 1.9 g of an ethanol extract. This extract was dissolved in DMS 0 at 1%, the concentration was adjusted by diluting this solution, and the following experiment was performed using this. Further, 100 g of the whole Fu portion of the hamburger (Hamula name: Brickel lia cavani llesy) was immersed in ethanol at room temperature for 1 week, the extract was concentrated, and the ethanol extract 2.1 g This extract was dissolved in DMS 0 at 1%, the concentration was adjusted by diluting this solution, and the following experiment was carried out using this.
- Mouse-derived B 16 melanoma cultured cells were used. 1 0% FBS Contact and Teofu I Li down '(0. 0 9 mg / m 1) by Lee Guru MEM medium containing C 0 2 Lee Nkyubeta one (95% air, 5% carbon dioxide) inside, 3 7 The culture was performed under the conditions of ° C.
- Kei Guy extract XXXX - - - 55 test Mela two - emissions generated luminous rating tyrosinase - peptidase activity index (3 ⁇ 4) Concentration (wt%) 10- 4 10- 3 10 L 10- 4 10 0 10- 2 Kokohiyui ⁇ extraction object X O O 92 73 0 elapsed "I extract XXX eleven 55 test Mera two generating luminous rating tyrosinase - peptidase activity index (3 ⁇ 4) concentration (wt%) 10" 4 10 one 3 10 2 10 4 10 " 3 10 Hamiyura extract X ⁇ ⁇ 76 0 0 Root extract XXX 11 OD 5. Whitening effect test
- UV-A + UV-B Subjects exposed to artificial light (UV-A + UV-B) for 30 minutes (10 minutes a day for 3 days) were exposed to sunlight on the inner skin of the upper arm of 40 subjects. After 5 days, each sample was applied once in the morning and evening for 4 weeks. The panel was divided into eight groups and divided into five groups, and the test was performed using the following formulation.
- the lightening effect after use was determined based on the following criteria.
- ⁇ When the proportion of the subjects who show significant efficacy and effectiveness is 80% or more ⁇ : When the proportion of the subjects who show great efficacy and efficacy is 50% to less than 80%
- Coco extract extract is obtained by reducing the branches of Coco extract by heating in ethanol, filtering, concentrating and drying.
- Hamyura extract is obtained by heating and reducing the whole plant of Hamyuula in ethanol, followed by filtration, concentration and drying. As is evident from Table 2, the effect after exposure to sunlight is better with the addition of the extract of Jurbaba-Paites, the extract of Kokohiyute, and the extract of Hami-yura to prevent the deposition of excess melanin pigment. However, it was recognized that the blackening was prevented.
- “Hamiyura extract” was obtained by heating and reducing the whole plant of “Hamiyura” in ethanol. After that, it was obtained by filtration, concentration and drying.
- Stearic acid 5.0% by weight Stearinol alcohol 4.0% Isopropyl myristate 18.0 Glycerin monostearic acid ester 3.0 Propylene glycol 10.0 Joules Beno. Citmethanol extract 0.01 caustic 0.2 Preservatives qs.Perfume qs
- Stearic acid 2.0% by weight Stearinol alcohol 7.0 Hydrogenated lanolin 2.0 Scoran 5.0
- phase Dissolve the carboxyvinyl polymer in a small amount of ion-exchanged water (phase).
- Polyethylene glycol 150 and triethanolamine are added to the remaining ion-exchanged water, and the mixture is heated and dissolved, and kept at 70 ° C (aqueous phase). Mix with other ingredients, heat and maintain at 70 ° C (oil phase).
- oil phase to water phase, pre-emulsify, add phase A, homogenize uniformly with homomixer, and after emulsification, cool to 30 ° C with good stirring.
- Glycerin 50 Dipropylene glycol 1.0 0 Sodium bisulfite 0 3 Carboxyvinyl polymer 0 2
- phase A and phase C Dissolve phase A and phase C uniformly, and add phase A to phase C for solubilization. Then, after adding phase B, filling is performed.
- phase A Dissolve phase A, phase B, and phase C uniformly, and add phase B to phase A for solubilization. Next, this is added to the C phase and then filled.
- Talc Thoroughly mix the powdery components of black iron oxide with a blender, and add the oily components of squalane-isoscetyl octoate, extract of julbeva pie-tuethanol. Add preservatives and fragrances, knead well, fill into containers and mold.
- phase A Dissolve the carboxyvinyl polymer in a small amount of ion-exchanged water (phase A).
- Phase A Add Polyethylene glycol 150 and Triethanolamine to the remaining ion-exchanged water, dissolve by heating, and keep at 70 ° C (aqueous phase). Mix with other ingredients, heat and maintain at 70 ° C (oil phase).
- Pre-emulsification by adding oil phase to water phase
- Add phase A homogenize with a homomixer, and cool to 30 ° C while stirring well.
- Carbopol 940 was uniformly dissolved in ion-exchanged water, while 95% ethanol was used to extract 50% aqueous ethanol extract, 50% ethanol, and polyoxyethylene (50 moles). ) Dissolve oleyl alcohol ether and add to the aqueous phase. Then, other
- phase A Dissolve phase A, phase B, and phase C uniformly, and add phase B to phase A for solubilization. Next, this is added to the C phase and then filled.
- Powdery components of talc and black iron oxide are mixed well with plunge, and the oily components of squalane and oxosethyl citrate are added to this product.
- Titanium dioxide 1 0.3% by weight Cerisite 5.4 Kaolin 3.0 Yellow iron oxide 0.8 Bengala 0.3 Black iron oxide 0.2
- a powder portion sufficiently mixed and pulverized is added, and a homomixer treatment is performed. Further, the oil phase mixed by heating is added, and the mixture is treated with a homomixer. Then, a fragrance is added with stirring, and the mixture is cooled to room temperature.
- Stearic acid 5.0% by weight Stearyl alcohol 4.0
- Isopropyl myristate 180
- Glycerin monostearate 30
- Propylene glycol 100
- Hamamiura Metabolic extract 0 0 1
- Caustic force 0 2
- Stearic acid 2.0% by weight Stearyl alcohol 7.0 Hydrogenated lanolin 2.0 Scoran 5.0
- phase A Dissolve carboxyvinyl polymer in a small amount of ion-exchanged water
- phase A Add polyethylene glycol 1500 and triethanolamine to the remaining ion-exchanged water, dissolve by heating, and maintain at 70 ° C (aqueous phase). Mix with other ingredients, heat and maintain at 70 ° C (oil phase).
- oil phase to water phase, pre-emulsify, add phase A, homogenize homogeneously with homomixer, and after emulsification, cool to 30 ° C while stirring well.
- Carbopol 940 is uniformly dissolved in ion-exchanged water, while 95% ethanol in ethanol and 50% ethanolic gel bush are extracted with 50% ethanol aqueous solution, polyoxyethylene (50%). Mol) o Reyl alcohol ether is dissolved and added to the aqueous phase. Next, after adding other components, the mixture is neutralized with caustic soda and L-arginine to increase the viscosity.
- phase A Dissolve phase A, phase B, and phase C uniformly, and add phase B to phase A for solubilization. Next, this is added to the C phase and then filled.
- Powdery components of talc to black iron oxide are mixed well in a blender, and oily components of squalane to isosethyl octanoate, Hamiura ethanol extract, preservative After adding perfume and kneading well, fill and mold into containers.
- Emulsion type foundation cream type
- Titanium dioxide 1 0.3% by weight cericite 5.4 Kaolin 3.0 Yellow iron oxide 0.8 Bengala 0.3 Black iron oxide 0.2
- the skin whitening preparation of the present invention has an effect of inhibiting melanin production and inhibiting tyrosinase activity, and has properties such as pigmentation after sunburn, spots, freckles, melasma, etc. It has excellent effects on lightening and whitening, as well as safety.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69823963T DE69823963T2 (de) | 1997-03-19 | 1998-03-16 | Dermatologische zusammensetzungen zur bleichung der haut |
EP98907242A EP0919218B1 (en) | 1997-03-19 | 1998-03-16 | Dermatological preparations for whitening the skin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8574697 | 1997-03-19 | ||
JP9/85746 | 1997-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998041183A1 true WO1998041183A1 (fr) | 1998-09-24 |
Family
ID=13867423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/001095 WO1998041183A1 (fr) | 1997-03-19 | 1998-03-16 | Preparations dermatologiques embellissantes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0919218B1 (ja) |
CN (1) | CN1123334C (ja) |
DE (1) | DE69823963T2 (ja) |
TW (1) | TW505520B (ja) |
WO (1) | WO1998041183A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1145709A1 (de) * | 2000-04-14 | 2001-10-17 | Laboratoires Serobiologiques | Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen |
FR2819718B1 (fr) * | 2001-01-22 | 2005-02-25 | Codif Internat Sa | Produit cosmetique |
WO2003057707A1 (en) | 2001-12-28 | 2003-07-17 | Suntory Limited | 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
FR2879446B1 (fr) * | 2004-12-20 | 2007-07-06 | Biolog Vegetale Yves Rocher Sa | Composition comprenant un extrait de cyclopia sp |
FR2886843B1 (fr) * | 2005-06-13 | 2007-08-17 | Am Phyto Conseil Sarl | Utilisation d'un extrait de griffonia, en particulier de griffonia simplicifolia dans une composition cosmetique ou dermatologique pour attenuer la pigmentation de la peau et des phaneres |
EP2571483B1 (en) | 2010-05-18 | 2014-12-03 | Unilever N.V. | A personal care composition |
CN102008412B (zh) * | 2010-11-26 | 2012-08-29 | 新时代健康产业(集团)有限公司 | 具有美白功效的护肤组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05345705A (ja) * | 1992-02-03 | 1993-12-27 | Nippon Shinyaku Co Ltd | 美白化粧料組成物 |
JPH0812565A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | 皮膚外用剤 |
JPH09249578A (ja) * | 1996-03-18 | 1997-09-22 | Yakurigaku Chuo Kenkyusho:Kk | チロシナーゼ賦活作用を指標とする生薬抽出物の臨床応用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2669032B1 (fr) * | 1990-11-14 | 1993-04-23 | Cecchi Georges | Procede de fabrication d'une preparation de d-alpha-tocopherol. |
JPH05163135A (ja) * | 1991-12-16 | 1993-06-29 | Suntory Ltd | 美白用化粧料組成物 |
JP3545057B2 (ja) * | 1994-08-31 | 2004-07-21 | 恒雄 難波 | 化粧料 |
FR2745182B1 (fr) * | 1996-02-22 | 1998-06-19 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant un extrait de solanum lycocarpum |
JPH1036216A (ja) * | 1996-07-22 | 1998-02-10 | Pola Chem Ind Inc | 皮膚化粧料 |
JPH11189514A (ja) * | 1997-12-25 | 1999-07-13 | Lion Corp | 毛髪化粧料 |
JPH11246344A (ja) * | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | 美白用皮膚外用剤 |
JPH11246343A (ja) * | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | 美白用皮膚外用剤 |
-
1998
- 1998-03-16 CN CN98800316A patent/CN1123334C/zh not_active Expired - Fee Related
- 1998-03-16 EP EP98907242A patent/EP0919218B1/en not_active Expired - Lifetime
- 1998-03-16 DE DE69823963T patent/DE69823963T2/de not_active Expired - Fee Related
- 1998-03-16 WO PCT/JP1998/001095 patent/WO1998041183A1/ja active IP Right Grant
- 1998-03-17 TW TW087103884A patent/TW505520B/zh not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05345705A (ja) * | 1992-02-03 | 1993-12-27 | Nippon Shinyaku Co Ltd | 美白化粧料組成物 |
JPH0812565A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | 皮膚外用剤 |
JPH09249578A (ja) * | 1996-03-18 | 1997-09-22 | Yakurigaku Chuo Kenkyusho:Kk | チロシナーゼ賦活作用を指標とする生薬抽出物の臨床応用 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0919218A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP0919218B1 (en) | 2004-05-19 |
TW505520B (en) | 2002-10-11 |
EP0919218A4 (en) | 2000-08-02 |
DE69823963D1 (de) | 2004-06-24 |
EP0919218A1 (en) | 1999-06-02 |
DE69823963T2 (de) | 2005-05-19 |
CN1123334C (zh) | 2003-10-08 |
CN1220595A (zh) | 1999-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0812565A (ja) | 皮膚外用剤 | |
JP3481386B2 (ja) | 美白用皮膚外用剤 | |
JPH11246347A (ja) | 美白用皮膚外用剤 | |
WO1998041183A1 (fr) | Preparations dermatologiques embellissantes | |
JPH0812561A (ja) | 美白用皮膚外用剤 | |
JPH0925209A (ja) | 皮膚外用剤 | |
JPH08310939A (ja) | 美白用皮膚外用剤 | |
KR20070057835A (ko) | 미백제 | |
JP3140357B2 (ja) | 美白用皮膚外用剤 | |
JPH0930945A (ja) | 皮膚外用剤 | |
JP2000159626A (ja) | 皮膚外用剤 | |
JPH0930949A (ja) | 美白用皮膚外用剤 | |
JP3270219B2 (ja) | 皮膚外用剤 | |
JP3527406B2 (ja) | 美白用皮膚外用剤 | |
JPH08301758A (ja) | 皮膚外用剤 | |
JPH0812552A (ja) | 皮膚外用剤 | |
JP4764079B2 (ja) | 美白剤 | |
JP2007126367A (ja) | 美白剤、美白方法および美白用皮膚外用剤の製造方法 | |
JPH11246344A (ja) | 美白用皮膚外用剤 | |
JP3263246B2 (ja) | 皮膚外用剤 | |
JPH11246343A (ja) | 美白用皮膚外用剤 | |
JPH0995436A (ja) | 皮膚外用剤 | |
JPH10265363A (ja) | チロシナーゼ阻害剤 | |
JPH11139952A (ja) | 美白用皮膚外用剤 | |
JPH0920635A (ja) | 美白用皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98800316.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09147238 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998907242 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019980709312 Country of ref document: KR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1998907242 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980709312 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998907242 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980709312 Country of ref document: KR |